Honey study

Manuka found to be pivotal in fight against MRSA

By RJ Whitehead

- Last updated on GMT

Manuka found to be pivotal in fight against MRSA
In what has been dubbed a “hugely important finding”, Australian researchers have found that medical-grade manuka honey can be used as a new weapon in the fight against drug-resistant bacteria, such as the MRSA superbug.

New Zealand manuka honey is known to have potent broad-spectrum antibacterial activity. But the results of this latest study show that using so-called Medihoney in combination with a well-known antibiotic, rifampicin, in the treatment of skin and chronic wound infections is highly effective, said Professor Liz Harry, who led the University of Technology Sydney team.

More than an additive

The combination of medical grade antibacterial honey with the antibiotic rifampicin, which is routinely used to prevent or treat chronic wound infections, is more effective at killing the bacteria methicillin-resistant Staphylococcus aureus (MRSA) than each treatment alone​,” she said, adding that the combination of medical Manuka with rifampicin is synergistic more than it is just an additive.

If MRSA were treated solely with rifampicin, the superbug became resistant very quickly. However, when Medihoney and rifampicin are used in combination to treat MRSA, rifampicin-resistant MRSA did not emerge. In other words, the honey somehow prevented the emergence of rifampicin-resistant MRSA – this is a hugely important finding.

Our results support the idea that the treatment of infected chronic wounds with rifampicin and Medihoney offers several benefits including more effective eradication of the infection, reduction of the effective dose of rifampicin, which reduces possible side effects and a reduction of the risk of antibiotic resistance both in the short term and long term​,” said Harry.

Used in combination

Rifampicin is one of the most effective drugs for treating chronic wound infections, but bacteria that are resistant to this drug so easily arise that it is always used in combination with other antibiotics to reduce or slow down resistance.

[The use of honey is] gaining momentum and it may not be long before it is routinely incorporated into future medical and hospital practice. Honey dressings in all types of formats are available and are economical to use routinely​.”

Source:"Synergism between Medihoney and Rifampicin against Methicillin-Resistant Staphylococcus aureus​(MRSA)." 2013, PLoS ONE 8(2): e57679. doi:10.1371/journal.pone.0057679
Authors: Müller P, Alber DG, Turnbull L, Schlothauer RC, Carter DA, et al. 

Related news

Show more

Related products

show more

Download the Brochure: APAC Agri-Food Innovation Summit

Download the Brochure: APAC Agri-Food Innovation Summit

Content provided by William Reed | 09-Aug-2024 | Product Brochure

The Asia-Pacific Agri-Food Innovation Summit, anchor event for SIAW, unites over 1000 global leaders every year to accelerate climate resilience and nutrition...

Pycnogenol® for a Healthy Summer

Pycnogenol® for a Healthy Summer

Content provided by Horphag Research | 19-Jul-2024 | White Paper

Pycnogenol® French maritime pine bark extract is the ideal ingredient for summer wellness with clinical research showing it helps mitigate allergy symptoms,...

Empowering Women Through the Life Cycle

Empowering Women Through the Life Cycle

Content provided by Glanbia Nutritionals | 07-Nov-2023 | Product Brochure

As discussions around female empowerment widen, and advances in women’s health access and provision accelerate, the implications for business, healthcare,...

Analyzing the unknown threat from Microplastics

Analyzing the unknown threat from Microplastics

Content provided by Agilent Technologies | 06-Nov-2023 | Infographic

Microplastics are any plastic-derived synthetic solid particle or polymeric matrix, ranging in size from 1 µm to 5 mm and insoluble in water.

Related suppliers

Follow us

Products

View more

Webinars

Food & Beverage Trailblazers